glp-1 drugs and gastroparesis Your guide to side effects GLP-1 drugs and aspiration risk

Here, we review the molecular mechanisms of the neuroprotective effects of GLP-1 RA in diabetes-related degenerative diseases, including AD and PD, and their potential effects

It also helps reduce hunger signals in the brain, enabling individuals to naturally consume fewer calories without persistent cravings

Hypoglycemia: Low risk with either medication when used alone

Given that liraglutide and semaglutide comprised the majority of studies, the results are most applicable to these agents, although the pooled analysis incorporated data from the entire GLP-1 RA class

This controls blood sugar levels

Significant weight reduction was seen, but bone mineral density (BMD) did not change